SAN DIEGO, Oct. 26 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) disclosed that today's presentation at the 4th Annual BIOCOM Investor Conference will be webcast live today. The presentation by Aethlon Chairman and CEO, James A. Joyce will begin at 2 p.m. pacific time and can be accessed on an audio-only basis at:

http://www.biocom.org/event/2009_Investor_Conference

(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)

About BIOCOM

BIOCOM is the largest regional life science association in the world, representing 550 member companies in Southern California. The association focuses on initiatives that position the region's life science industry competitively on the world stage, and on the development and delivery of innovative products that improve health and quality of life. This includes initiatives in capital formation, public policy, workforce development, and member services. For more information on BIOCOM or the Southern California biotechnology and medical device community, please visit the organization's website at http://www.biocom.org.

About Aethlon Medical

Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.

    Contacts:

    RedChip Companies, Inc.
    Jon Cunningham
    1-800-733-2447, Ext. 107
    Jon@redchip.com

    Jim Joyce
    Chairman, CEO
    858.459.7800 x301
    jj@aethlonmedical.com

    Jim Frakes
    Senior VP Finance
    858.459.7800 x300
    jfrakes@aethlonmedical.com

SOURCE Aethlon Medical, Inc.